Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul R. Ervin
Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines
PLoS ONE
Multidisciplinary
Related publications
Distinct P53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers
Clinical Cancer Research
Cancer Research
Oncology
Estrogen Receptor (ER) mRNA Expression and Molecular Subtype Distribution in ER-negative/progesterone Receptor-Positive Breast Cancers
Breast Cancer Research and Treatment
Cancer Research
Oncology
Genetically Engineered ER -Positive Breast Cancer Mouse Models
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
Glucocorticoid Receptor Modulation Decreases ER-positive Breast Cancer Cell Proliferation and Suppresses Wild-Type and Mutant ER Chromatin Association
Breast Cancer Research
Cancer Research
Oncology
Prohibitin Promotes Androgen Receptor Activation in ER-positive Breast Cancer
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
PLoS ONE
Multidisciplinary
Estrogen Therapy Induces an Unfolded Protein Response to Drive Cell Death in ER + Breast Cancer
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Identification of Potential Glycoprotein Biomarkers in Estrogen Receptor Positive (ER+) and Negative (ER-) Human Breast Cancer Tissues by LC-LTQ/FT-ICR Mass Spectrometry
Journal of Cancer
Oncology
Moesin Is an Independent Prognostic Marker for ER‑positive Breast Cancer
Oncology Letters
Cancer Research
Oncology